Gadolinium-based contrast brokers (GBCAs) are commonly Employed in magnetic resonance imaging (MRI) to improve the visibility of blood vessels, tumors, inflammation, along with other inner structures. Although normally viewed as Safe and sound, problems about GBCA toxicity have emerged in the last 20 years—notably in sufferers with impaired kidne